Tradestie Institutional Equity Comparison Engine
SRZN vs EVGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SRZN Overall Edge
SRZN Captures Institutional Edge (3โ0 Pillars ยท 7โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Surrozen, Inc. Common (SRZN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SRZN trades at N/M Forward P/E with -485.4% operating margin (+408.6% YoY revenue) versus EVGN at N/M Forward P/E and -858.2% operating margin (-60.7% YoY). In options structure, SRZN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against EVGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SRZN N/M vs EVGN N/M Fwd P/E
Growth & Margin Winner
SRZN
Op Margin -485.4% vs -858.2% ยท YoY +408.6% vs -60.7%
Momentum & Technical Winner
SRZN
1Y +131.0% vs -71.9% ยท 52W Pos 69% vs 9%
Options & Structure Winner
SRZN
CONSOLIDATION (5th %ile IV) vs UNCLASSIFIED (N/A IV)
SRZN
NASDAQ
Surrozen, Inc. Common
Biological Products, (No Disgnostic Substances)
$29.98
-7.24% 1D
Market Cap
$616.1M
1M Return
+25.76%
1Y Return
+130.97%
Forward P/E
N/M
Unified AI Score
46.6 / 100
HOLD
Tech 40.0
Fund 33.0
Flow 65.0
Mom 40.0
EVGN
NASDAQ
Evogene Ltd.
Agricultural Chemicals
$0.34
-13.17% 1D
Market Cap
$6.0M
1M Return
-7.58%
1Y Return
-71.89%
Forward P/E
N/M
Unified AI Score
44.1 / 100
HOLD
Tech 42.0
Fund 44.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SRZN +130.97%
EVGN -71.89%
Spread: +202.86 pp (SRZN Lead)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | SRZN Revenue | EVGN Revenue | SRZN Op. Margin | EVGN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q3 '25 | $0M | $0M | -1107.3% | -873.1% | EVGN |
| Q4 '25 | $0M | $0M | -2393.8% | -1659.9% | EVGN |
| Q1 '26 | $20M | $0M | -209.1% | -943.1% | SRZN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SRZN | EVGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $616.1M | $6.0M | Larger Scale | SRZN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +408.6% | -60.7% | Higher Growth | SRZN |
| Operating Margin (TTM) Profitability | -485.4% | -858.2% | Higher Margin | SRZN |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -62.8% | -182.8% | Higher ROE | SRZN |
| 52-Week Range Position Momentum | 69% ($12โ$38) | 9% ($0โ$1) | Stronger Trend | SRZN |
| Beta / 30D Volatility Risk Regime | 1.29ฮฒ ยท 67% Vol | 1.37ฮฒ ยท 138% Vol | Lower Realized Risk | SRZN |
| Unified Institutional Score Composite Signal | 46.6 / 100 (HOLD) | 44.1 / 100 (HOLD) | Higher Composite | SRZN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SRZN vs EVGN Buy Guide
SRZN
CONSOLIDATION
38d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
EVGN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SRZN nor EVGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.